JP3167777B2 - Antiviral, antibacterial and bactericide - Google Patents
Antiviral, antibacterial and bactericideInfo
- Publication number
- JP3167777B2 JP3167777B2 JP08471992A JP8471992A JP3167777B2 JP 3167777 B2 JP3167777 B2 JP 3167777B2 JP 08471992 A JP08471992 A JP 08471992A JP 8471992 A JP8471992 A JP 8471992A JP 3167777 B2 JP3167777 B2 JP 3167777B2
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial
- extract
- antiviral
- linealis
- bactericide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、豆科に属するアスパラ
サス・リネアリスの含有成分を有効成分として、抗ウイ
ルス剤、抗菌・殺菌剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antiviral agent, an antibacterial agent and a bactericidal agent containing as an active ingredient an ingredient of Asparasacea linealis belonging to the legume family.
【0002】[0002]
【従来の技術】従来より、抗菌剤、殺菌剤は数多く知ら
れている。2. Description of the Related Art Conventionally, many antibacterial agents and bactericides are known.
【0003】[0003]
【発明が解決しようとする課題】しかし、これらのもの
は、ほとんどがバクテリアに作用するもので、ウイルス
あるいはカビ類に効くものはあまり知られておらず、ま
た効力も弱く、さらに副作用があり、人体に危険なもの
が多い。However, most of these substances act on bacteria, and those that act on viruses or molds are not well known, and their efficacy is weak and they have side effects. There are many things that are dangerous to the human body.
【0004】また、ウイルス性疾患にはインフルエン
ザ、肝炎、麻疹、日本脳炎、成人T細胞白血病、あるい
はエイズなど多くの疾患があるが、このようなウイルス
に対して有効な薬剤は多くなく、またその効果が明確で
なく、特に成人T細胞白血病あるいはエイズウイルスの
ようなレトロウイルスに効果のあるものは余り知られて
いない。There are many viral diseases such as influenza, hepatitis, measles, Japanese encephalitis, adult T-cell leukemia and AIDS, but there are not many drugs effective against such viruses, and The effect is not clear, and there is no known effect which is particularly effective against retroviruses such as adult T-cell leukemia or AIDS virus.
【0005】さらに、人体に害がなく日常飲食も可能で
予防効果を有するような抗ウイルス、抗菌・殺菌剤は知
られていない。[0005] Further, there is no known antiviral, antibacterial or bactericidal agent which has no harm to the human body, can be eaten and consumed daily and has a preventive effect.
【0006】本発明は、前記課題を解決し、レトロウイ
ルスに効果があり、また、副作用がなく、予防効果を有
する抗ウイルス、抗菌・殺菌剤を提供することを目的と
する。An object of the present invention is to provide an antiviral, antibacterial and bactericidal agent which solves the above-mentioned problems, is effective against retroviruses, has no side effects, and has a preventive effect.
【0007】[0007]
【課題を解決するための手段】そこで、本発明者らは、
前記目的を解決するために鋭意研究を重ねた結果、豆科
に属するアスパラサス・リネアリス抽出物が、抗ウイル
ス、抗菌・殺菌作用が強く、かつ人体、家畜などに対し
て副作用がなく安全な抗ウイルス、抗菌・殺菌剤である
との知見を得て本発明を完成した。Means for Solving the Problems Accordingly, the present inventors have:
As a result of intensive studies to solve the above-mentioned object, asparathus linealis extract belonging to the legume family has a strong antiviral, antibacterial and bactericidal action, and is a safe anti- body with no side effects on the human body and livestock. The present invention was completed based on the finding that it was a virus or an antibacterial / bactericidal agent.
【0008】本発明の有効成分は、アスパラサス・リネ
アリスの抽出液からなり、抽出法としては、アスパラサ
ス・リネアリスの葉または茎を水及び/または有機溶媒
で抽出し、該抽出液より抽出溶媒を留去する方法、また
はアスパラサス・リネアリスの葉または茎を粉砕するこ
とによって得ることができる。また、通常の日本茶、中
国茶、紅茶などの製法と同様に抽出してもよい。[0008] The active ingredient of the present invention comprises an extract of Asparathus linealis, which is extracted by extracting leaves or stems of Asparathus linealis with water and / or an organic solvent, and extracting the extraction solvent from the extract. , Or by pulverizing the leaves or stems of Asparasas linealis. Moreover, you may extract similarly to the manufacturing method of normal Japanese tea, Chinese tea, black tea, etc.
【0009】水で抽出する場合には、アスパラサス・リ
ネアリスの50〜1000倍の水を加え、沸騰後、さら
に5〜30分程度沸騰抽出するのが好ましい。また、通
常の茶と同様抽出するときは、アスパラサス・リネアリ
スの乾燥葉の50〜500倍の80〜100度の湯で3
〜30分程度放置して抽出液を得る。In the case of extraction with water, it is preferable to add 50 to 1000 times the amount of water of Asparasaceae linealis, and after boiling, extract by boiling for about 5 to 30 minutes. In addition, when extracting the tea in the same manner as ordinary tea, use hot water at 80 to 100 degrees, which is 50 to 500 times the dried leaves of Asparasacea lineas, and
Leave for about 30 minutes to obtain an extract.
【0010】有機溶媒の具体例としては、メタノール、
エタノール、アセトン等が挙げられ、抽出にあたって温
時抽出等慣用手段を用いることができる。また、抽出液
の分離も、デカンテーションや遠心分離等の慣用手段を
用いることができる。Specific examples of the organic solvent include methanol,
Ethanol, acetone and the like can be mentioned, and conventional means such as warm extraction can be used for the extraction. In addition, for separation of the extract, conventional means such as decantation and centrifugation can be used.
【0011】抽出溶媒の留去も凍結乾燥等の慣用手段を
用いることができる。また、アスパラサス・リネアリス
そのものを粉砕し、粉末化して用いることもできる。The extraction solvent can be distilled off by conventional means such as freeze-drying. In addition, asparasas linealis itself can be crushed and powdered for use.
【0012】本組成物は、有効成分を生理学的に許容さ
れうる担体、賦形剤、結合剤、希釈剤と混合し、たとえ
ば顆粒剤、粉剤、硬カプセル剤、軟カプセル剤、塗布
剤、シロップ、坐剤、注射剤として経口または非経口的
に、または、混合してそのまま溶液、粉末顆粒、錠剤、
乳剤、ゼリー状など任意の形態で単独投与、濃縮液を利
用、または他の飲食物に混合して飲食することもでき
る。The composition is obtained by mixing the active ingredient with physiologically acceptable carriers, excipients, binders and diluents, for example, granules, powders, hard capsules, soft capsules, coatings and syrups. , Suppositories, orally or parenterally as injections, or mixed as is, solutions, powder granules, tablets,
It may be administered alone in an arbitrary form such as an emulsion or jelly, a concentrated solution may be used, or mixed with other food and drink.
【0013】投与量は、対象となる疾患の種類、程度に
より異なるが、飲料として常用する場合には、1〜5g
/l溶液を100ml〜1500ml/日飲食するのが
好ましい。The dosage varies depending on the type and degree of the disease to be treated, but when it is commonly used as a drink, it is 1 to 5 g.
It is preferable to eat and drink 100 ml / l solution / day to 100 ml / day.
【0014】アスパラサス・リネアリスは、ラットに対
する急性毒性試験で死亡例は皆無であり、生化学血液検
査及び病理組織学的検査においても異常が認められなか
った。Asparasas linealis had no deaths in an acute toxicity test on rats, and no abnormalities were observed in biochemical blood tests and histopathological tests.
【0015】[0015]
【効果】本発明は、ウイルス、細菌、カビなど各種微生
物の成育を抑え、また殺菌し、レトロウイルスに効果が
あり、また、副作用がなく、予防効果を有する抗ウイル
ス、抗菌・殺菌剤することができる。[Effect] The present invention is to provide an antiviral, antibacterial and bactericidal agent which suppresses the growth of various microorganisms such as viruses, bacteria and molds, sterilizes it, has an effect on retroviruses, has no side effects and has a preventive effect. Can be.
【0016】[0016]
製造例 採取したアスパラサス・リネアリスの葉(茎つき)を、
5mm長に切断後、ローリング、酵素 酵、天日乾燥の
工程を経て乾燥葉とする。乾燥葉1〜5gを水1.5〜
2lで5〜30分間沸騰させ抽出液を得た。Production example The leaves (with stem) of the collected asparasas linealis are
After cutting to a length of 5 mm, the leaves are subjected to rolling, enzymatic fermentation, and sun drying to obtain dried leaves. 1-5 g of dried leaves in 1.5-
The mixture was boiled with 2 l for 5 to 30 minutes to obtain an extract.
【0017】実施例1 製造例で得た抽出液を、減菌後寒天培養地に加え通常の
コントロール群と微生物の生育状況を調べた。その結果
を表1に示す。Example 1 The extract obtained in the Production Example was sterilized, added to an agar culture site, and examined for a normal control group and the growth of microorganisms. Table 1 shows the results.
【表1】 [Table 1]
【0018】製造例で得た抽出液を、滅菌後ニワトリの
卵にインフルエンザウィルスを感染させてウィルスの増
殖の程度を調べた。その結果を表2に示す。After the extract obtained in the Production Example was sterilized, chicken eggs were infected with an influenza virus, and the degree of virus proliferation was examined. Table 2 shows the results.
【表2】 [Table 2]
【0019】製造例で得たアスパラサス・リネアリスの
抽出液を減菌後、各種希釈濃度になるように培地に添加
し、表3に示した細菌の育成状況を調べ、各種育成阻害
の最低濃度を表3に示した。After sterilizing the extract of Asparagus lineaealis obtained in the production example, the extract was added to the medium at various dilution concentrations, and the growth status of the bacteria shown in Table 3 was examined. Are shown in Table 3.
【表3】 [Table 3]
【0020】アスパラサス・リネアリスの化学分析結果
は下記の通りである。 鉄 23.40mg/100g カルシウム 187.00mg/100g カリウム 398.00mg/100g マグネシウム 207.00mg/100g 銅 2.25ppm 亜鉛 6.74ppm セレン 0.13ppm ビタミンE 17.00mg/100g たんぱく質 8.00% フラボノイド 41.00mg/100g SOD力価 69,000unit/g 酸不溶性蛋白成分 150mg/100g 香気成分 100mg/100g 糖含有化合物 690mg/100gThe results of the chemical analysis of Asparasas linearis are as follows. Iron 23.40 mg / 100 g Calcium 187.00 mg / 100 g Potassium 398.00 mg / 100 g Magnesium 207.00 mg / 100 g Copper 2.25 ppm Zinc 6.74 ppm Selenium 0.13 ppm Vitamin E 17.00 mg / 100 g Protein 8.00% Flavonoid 41 0.000 mg / 100 g SOD titer 69000 units / g Acid-insoluble protein component 150 mg / 100 g Flavor component 100 mg / 100 g Sugar-containing compound 690 mg / 100 g
【0020】また香気成分として、カルボニル化合物
(15%)、カロチノイド分解物(17%)、炭素数2
〜12の有機酸(22%)、フェノール化合物(13
%)、芳香族含酸素化合物(7%)、芳香族炭化水素
(5.5%)、テルペノイド(4%)などを含有する。
なお、酸不溶性蛋白質とは比較的分子量の大きな蛋白成
分である。As fragrance components, carbonyl compounds (15%), carotenoid decomposition products (17%),
To 12 organic acids (22%), phenol compounds (13
%), An aromatic oxygen compound (7%), an aromatic hydrocarbon (5.5%), a terpenoid (4%), and the like.
The acid-insoluble protein is a protein component having a relatively large molecular weight.
───────────────────────────────────────────────────── フロントページの続き 審査官 鶴見 秀紀 (58)調査した分野(Int.Cl.7,DB名) A61K 35/78 A01N 65/00 A61P 31/00 BIOSIS(DIALOG) CA(STN) MEDLINE(STN) WPI/L(QUESTEL)────────────────────────────────────────────────── ─── Continued on the front page Examiner Hideki Tsurumi (58) Field of investigation (Int. Cl. 7 , DB name) A61K 35/78 A01N 65/00 A61P 31/00 BIOSIS (DIALOG) CA (STN) ) WPI / L (QUESTEL)
Claims (1)
成分とする抗菌・殺菌剤。1. An antibacterial and bactericidal agent comprising an extract of Asparagus lineaealis as an active ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP08471992A JP3167777B2 (en) | 1992-03-06 | 1992-03-06 | Antiviral, antibacterial and bactericide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP08471992A JP3167777B2 (en) | 1992-03-06 | 1992-03-06 | Antiviral, antibacterial and bactericide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05271062A JPH05271062A (en) | 1993-10-19 |
| JP3167777B2 true JP3167777B2 (en) | 2001-05-21 |
Family
ID=13838493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP08471992A Expired - Fee Related JP3167777B2 (en) | 1992-03-06 | 1992-03-06 | Antiviral, antibacterial and bactericide |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3167777B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495811B2 (en) | 2000-12-11 | 2002-12-17 | Agfa-Gevaert Ag | Induction heating device and method, and processor |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3290834B2 (en) * | 1994-11-25 | 2002-06-10 | 昌俊 中野 | Antiviral agent and method for producing the same |
| JP3793593B2 (en) * | 1995-07-31 | 2006-07-05 | 中野 昌俊 | Method for producing antiviral agent |
| JP5917164B2 (en) * | 2012-01-25 | 2016-05-11 | クラシエホームプロダクツ株式会社 | Antibacterial / bactericidal agent and therapeutic / preventive agent for atopic dermatitis |
| KR101864263B1 (en) * | 2017-08-22 | 2018-06-04 | 김봉출 | Natural preservative compisition for cosmetics |
-
1992
- 1992-03-06 JP JP08471992A patent/JP3167777B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495811B2 (en) | 2000-12-11 | 2002-12-17 | Agfa-Gevaert Ag | Induction heating device and method, and processor |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05271062A (en) | 1993-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3193898B1 (en) | Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system | |
| JP2016063805A (en) | Inactivation of various miscellaneous viruses such as Ebola virus, HIV, IFV (hereinafter abbreviated as virus), the positron (+ ion) with which the skin of the virus is charged, zeolite, and ion exchange A method of inactivating viruses by exchanging and replacing negatively charged electrons (-ions) where the resin is charged. | |
| JP3167777B2 (en) | Antiviral, antibacterial and bactericide | |
| JP2014042514A (en) | Formation of antigen-antibody complex by which human body acquires autoimmunity, using blood collected from mammal such as human body and swine or poultry infected with hiv, ifv, new coronavirus, sars coronavirus or other virus, or malaria parasite, and formation method thereof | |
| KR101046787B1 (en) | Hangover drink composition | |
| JP2011020925A (en) | Offal fat-type overweight inhibitor and method for producing the same | |
| JPH06199695A (en) | Agent for amelioration and treatment of diabetes | |
| Khumlianlal et al. | Analysis of nutritional value, antiviral potential and in vivo toxicological evaluation of Termitomyces clypeatus R. Hiem mycelial extract, a wild edible mushroom | |
| JPH06199697A (en) | Antiviral, antibacterial and fungicidal agent | |
| JPH0840923A (en) | Nutrient-supplying agent | |
| JP6975425B2 (en) | Anti-norovirus composition and its use | |
| JP5002127B2 (en) | Hypoglycemic composition containing acacia bark | |
| JPH08151329A (en) | Antiviral agent, anticancer agent, and method for producing the same | |
| JPH01238532A (en) | Antiinfectant | |
| JP2724524B2 (en) | Constipation improvement / treatment agent | |
| JP3167776B2 (en) | Anticancer / anticancer agent | |
| Okukpe et al. | Stress modulating effect of crude leaf extract of Vernonia amygdalina in captive grasscutter (Thryonomys swinderianus). | |
| JP3154544B2 (en) | Inflammatory disease improving therapeutic agent | |
| KR20190119020A (en) | A composition for anti-inflammation comprising hemistepta lyrata extract | |
| JOEL et al. | REGULAR ARTICLE TOXICOLOGICAL EVALUATION OF AQUEOUS LEAF EXTRACT OF SPONDIAS MOMBIN USING ALBINO RAT | |
| WO1998024458A1 (en) | Substance in the form of an aqueous extract of vegetal raw material for treating oncological diseases, and method for producing the same | |
| JP5651834B2 (en) | Hemagglutination inhibitor and method for inhibiting erythrocyte aggregation | |
| JP2008247797A (en) | Prophylactic agent, therapeutic agent and pharmaceutical composition for adult T-cell leukemia | |
| JP2006342073A (en) | Immunoactivity-enhancing ingredient, and food/drink and quasi-drug each containing the same | |
| JP4974475B2 (en) | Composition for prevention and / or treatment of pruritus containing acacia bark-derived material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080309 Year of fee payment: 7 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080309 Year of fee payment: 7 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080309 Year of fee payment: 7 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| LAPS | Cancellation because of no payment of annual fees |